Human CCL15/MIP-1 delta Antibody, R&D Systems™

CCL15/MIP-1 delta

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

chemokine (C-C motif) ligand 15, Chemokine CC-2, HCC-2, HCC-2Lkn-1, leukotactin 1, Leukotactin-1, LKN1, LKN-1, Macrophage inflammatory protein 5, MIP1 delta, MIP-1 delta, MIP5, MIP-5, MIP-5MIP-1d, Mrp-2b, NCC-3, NCC-3MIP-1D, NCC3MRP-2B, new CC chemokine 3, SCYA15member 15, Small-inducible cytokine A15

Goat

Affinity Purified

RUO

6359

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot, Neutralization

LYOPH

Western Blot 0.1 ug/mL, Neutralization 1-5 ug/mL

Q16663

CCL15

E. coli-derived recombinant human CCL15/MIP-1 delta Gln22-Ile113 Accession # Q16663

25 μg

Primary

Detects human CCL15/MIP-1 delta in direct ELISAs and Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant human (rh) MPIF-1 is observed and less than 1% cross-reactivity with rhMIP-1 alpha is observed.

Human

IgG